Virica Logo

Virica Biotech Announces Industry Veteran, Beth Thompson-Webb, as Chief Commercial Officer

2023-01-05T10:04:05-05:00

Ottawa, Canada- January 5th, 2023- Virica Biotech Inc. ("Virica"), a leading supplier and developer of viral enhancers for scaling of viral medicines, announced today that Beth Thompson-Webb will be joining the company as Chief Commercial Officer (CCO), effective January 9, 2023. Based out of Boston, MA, Ms. Thompson-Webb will be leading Virica’s commercial efforts to drive [...]

Virica Biotech Announces Industry Veteran, Beth Thompson-Webb, as Chief Commercial Officer2023-01-05T10:04:05-05:00

Virica Biotech to be Showcased in Xtalks Webinar: Process Intensification in AAV Gene Therapy

2022-11-04T10:15:36-04:00

Virica Biotech Inc. (“Virica”), a leading developer of solutions for scaling of viral medicines, will be featured in a live webinar to be held on Monday, November 14, 2022, at 2:30pm EST. This webinar will focus on process intensification in the manufacturing of adeno associated virus (AAV) vectors. Tune into this free webinar to learn [...]

Virica Biotech to be Showcased in Xtalks Webinar: Process Intensification in AAV Gene Therapy2022-11-04T10:15:36-04:00

Virica Biotech Wins Top Abstract Award at ISCT 2022

2022-08-03T09:22:41-04:00

Virica Biotech Awarded Best Abstract at ISCT 2022-San Francisco Our Data Scientist, Andrea Vervoot and VP of Scientific Operations, JonDavid De Jong represented Virica at International Society of Cell & Gene Therapy (ISCT) 2022 in San Francisco. Andrea Vervoot's abstract presentation on the Bioprocess Modelling of Upstream Viral Vector Production Enhancement won the Best Elevator [...]

Virica Biotech Wins Top Abstract Award at ISCT 20222022-08-03T09:22:41-04:00

Virica Biotech Announces Collaboration with the Government of Canada

2022-05-02T07:56:49-04:00

For Immediate Release Virica Biotech Announces Collaboration with the Government of Canada to Make Gene Therapies More Accessible and Affordable for Canadians  Download full press release here. Ottawa, Canada – May 2, 2022 –Virica Biotech Inc. (“Virica”), a leading developer of solutions for scaling of viral medicines, today announced it has received $400,000 from Innovation, [...]

Virica Biotech Announces Collaboration with the Government of Canada2022-05-02T07:56:49-04:00

Virica Biotech Announces R&D Partnership with Oxford BioMedica

2022-02-04T08:52:54-05:00

OTTAWA ,Canada– January 24th, 2022 – Virica Biotech Inc., a leading developer of solutions for scaling of viral medicines, today announced it will collaborate with Oxford BioMedica plc (LSE:OXB), a leading gene and cell therapy company, to improve the yield and production efficiency of Oxford Biomedica's next generation lentiviral vector gene therapies using Virica's [...]

Virica Biotech Announces R&D Partnership with Oxford BioMedica2022-02-04T08:52:54-05:00
Go to Top